October 2008 Issue - Endovascular Today

Table of Contents

Issue

October 2008

Supplement

View Supplement

In This Issue

Chief Medical Editor's Page

Exploring Options in the SFA

By John R. Laird, Jr, MD, Chief Medical Editor

Techniques

Remote Endarterectomy

This minimally invasive procedure is a viable treatment option for many patients with peripheral vascular disease.

By David Rosenthal, MD; Eric D. Wellons, MD; Allison B. Burkett, MD; and Paul V. Kochupura, MD

Cover Story

Excisional Atherectomy: Workhorse or Niche?

Where does excisional atherectomy work best for lower extremity arterial occlusive disease?

By Michael C. Nguyen, MD, and Lawrence A. Garcia, MD

Scoring and Cutting Balloons for SFA Disease Treatment

The role of these devices for percutaneous intervention in this challenging anatomy.

By Marc Bosiers, MD; Koen Deloose, MD; Jurgen Verbist, MD; and Patrick Peeters, MD

Covered Stents for the Treatment of SFA Occlusive Disease

A case-based discussion of stent graft use in this challenging anatomy.

By Subhash Banerjee, MD; Emmanouil S. Brilakis, MD, PhD; and Tony S. Das, MD

Drug-Coated Balloons

Paclitaxel-coated balloons show promise as a treatment option for intravascular interventions.

By Gunnar Tepe, MD, and Ulrich Speck, Phd

Practical Uses of Cryoplasty

A look at some of the effective applications of this nonsurgical treatment option.

By Pranab Das, MD; Santosh K. Koshy, MD; Robert S. Dieter, MD, RVT; and Aravinda Nanjundappa, MD, RVT

Lessons Learned in RESILIENT

Co-Principal Investigator John R. Laird Jr, MD, discusses the results and impact of this landmark SFA stenting trial.

The Zilver PTX Global Registry and RCT

Michael D. Dake, MD, discusses the early experiences in the Zilver PTX randomized trial and the results seen in the larger global registry studying a paclitaxel-eluting stent in the SFA.

The DURABILITY II Trial

Krishna Rocha-Singh, MD, FACC, FSCAI, discusses the current status of the DURABILITY II trial, a challenging landmark study of patency and fracture resistance of stenting in the superficial femoral and popliteal arteries.

Coding & Reimbursement

CMS Withdraws CCI Policy Change

The Correct Coding Initiative policy decision is good news for endovascular physicians.

By Jackie Miller, RHIA, CPC

An Interview with Jos C. van den Berg, MD, PhD

A leading interventional radiologist discusses vascular closure, differences between CE Mark and FDA approval, and highlights of his current research.

By Jos C. van den Berg, MD, PhD

Innovations